Systematic Evaluation of Plasma and Urine Metabolites to Predict the Risk of Adverse Kidney-related Outcomes in Chronic Kidney Disease: The GCKD Study∗.

Kidney Med · 2026 · PMC13293684 · PMID 42369268

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

partially significantno p-value reported

Overall, multimetabolite models demonstrated modest, partially significant improvements over clinical models, and were comparable to other suggested prognostic models of KF.

also in 417 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.